Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

NCT06221813 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Nipah Virus Infection

Interventions

BIOLOGICAL: PHV02
BIOLOGICAL: Lactated Ringer's

Sponsor

Public Health Vaccines LLC

Collaborators

[object Object]